Dong Xue, Luo Jingfeng, Lan Pengxun, Guo Xiuyu, Zhao Xin, Wang Xiaoyan, Zhou Fei, Wang Qiangfeng, Yuan Hong, Sun Jihong
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, No. 3 East Qingchun Road, Hangzhou, 310016, Zhejiang, China.
Department of Radiology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo, 315000, China.
Eur Radiol. 2021 Jul;31(7):4615-4624. doi: 10.1007/s00330-020-07609-8. Epub 2021 Jan 6.
To develop a nanoparticle-based MRI protocol based on transrectal administration of intestine-absorbable nanoparticle contrast agents to evaluate ulcerative colitis (UC).
Solid lipid nanoparticles (SLNs) were synthesized by loading gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA) and octadecylamine-fluorescein isothiocyanate to produce Gd-FITC-SLNs as T1 contrast agents. Twenty mice with acute UC were divided into four groups: enema with Gd-FITC-SLNs, intravenous injection of Gd-FITC-SLNs, enema with Gd-DTPA, and intravenous injection of Gd-DTPA. Five mice with chronic UC and five mice without UC underwent enema with Gd-FITC-SLNs. Axial T1- and T2-weighted MR images were obtained before and 20, 40, 60, 80,100, and 120 min after enema or intravenous injection of the contrast agent. The signal-to-noise ratios (SNRs) of the colorectal wall were measured in both groups. The MRI findings were correlated with subsequent histological confirmation.
At 20 min after enema with Gd-FITC-SLNs, MRI showed the following contrast enhancement pattern: acute UC > normal intestinal wall > chronic UC. A continuous enhancement effect was observed in mice with acute UC, whereas a slight continuous enhancement of the colorectal wall was observed in mice with chronic UC. The normal intestinal wall rapidly metabolized the contrast agent, and the enhancement decreased on sequential scans. There was no significant difference between the SNRs of the intestinal wall at 20 min after intravenous Gd-DTPA and transrectal Gd-FITC-SLN administration.
Enema with Gd-FITC-SLNs may be helpful for the diagnosis and differential diagnosis of acute and chronic UC and can confer the same or better results than with intravenous Gd-DTPA.
• Enema with Gd-FITC-SLNs may be helpful for the diagnosis and differential diagnosis of acute and chronic UC. • Enema with Gd-FITC-SLNs can achieve the same or better result than that with intravenous Gd-DTPA. • SLN-based MR colonography enhances the colorectal wall inflammation, based on the colonic absorption of the nanoparticle contrast agents.
基于经直肠给予肠道可吸收纳米颗粒造影剂开发一种基于纳米颗粒的磁共振成像(MRI)方案,以评估溃疡性结肠炎(UC)。
通过负载钆二乙烯三胺五乙酸(Gd-DTPA)和十八烷基胺-异硫氰酸荧光素合成固体脂质纳米颗粒(SLN),制备Gd-FITC-SLN作为T1造影剂。将20只急性UC小鼠分为四组:Gd-FITC-SLN灌肠组、Gd-FITC-SLN静脉注射组、Gd-DTPA灌肠组和Gd-DTPA静脉注射组。对5只慢性UC小鼠和5只无UC小鼠进行Gd-FITC-SLN灌肠。在灌肠或静脉注射造影剂前以及注射后20、40、60、80、100和120分钟获取轴位T1加权和T2加权MR图像。测量两组结直肠壁的信噪比(SNR)。将MRI结果与随后的组织学证实结果进行关联。
Gd-FITC-SLN灌肠后20分钟,MRI显示以下对比增强模式:急性UC>正常肠壁>慢性UC。急性UC小鼠观察到持续增强效应,而慢性UC小鼠结直肠壁有轻微持续增强。正常肠壁迅速代谢造影剂,连续扫描时增强减弱。静脉注射Gd-DTPA后20分钟与经直肠给予Gd-FITC-SLN后肠壁的SNR之间无显著差异。
Gd-FITC-SLN灌肠可能有助于急性和慢性UC的诊断及鉴别诊断,并且能产生与静脉注射Gd-DTPA相同或更好的结果。
• Gd-FITC-SLN灌肠可能有助于急性和慢性UC的诊断及鉴别诊断。• Gd-FITC-SLN灌肠能取得与静脉注射Gd-DTPA相同或更好的结果。• 基于纳米颗粒造影剂的结肠吸收,基于SLN的MR结肠造影增强了结直肠壁炎症。